⚠ Evidence warning: Clinical trials or other evidence do not support the claims that the peppermint effect follows the cooling-sensation timeline and reflects a measurable change in central pain processing, that the full effect peaks at about 30 minutes, that about half of menthol users were pain-free or in mild pain at 2 hours, that the safety profile in migraine was excellent, that peppermint and acetaminophen share one final pathway, and that peppermint and camphor-menthol balms have the best evidence base. This page keeps it as a report of what people, websites or other media say.
Peppermint for Headache Relief
Topical peppermint oil for tension headache is one of the most thoroughly validated "old folk remedy" treatments in modern clinical neurology. The pivotal trial — Göbel and colleagues at the University of Kiel, published in 1996 — gave 41 patients all four treatments across 164 headache attacks in a crossover design (10% peppermint oil in ethanol applied to the temples and forehead, 1,000 mg oral acetaminophen, both, or double placebo) and tracked tension-headache pain at 15-minute intervals. The result: topical peppermint oil produced statistically significant pain reduction by 15 minutes post-application, with no significant difference in effect from 1,000 mg acetaminophen, and the combination gave an extra effect that stayed below statistical significance. The mechanism is TRPM8 cold-receptor activation in the trigeminal cutaneous branches over the forehead and temples, producing a counter-irritant effect that crowds out competing tension-headache pain signaling at the central level. Additional applications include menthol applied to the skin for migraine attacks (the Borhani Haghighi 2010 trial), peppermint-oil nose drops for migraine (one 2019 trial), and the inclusion of peppermint or menthol in many over-the-counter headache balms and menthol creams. This page covers the trials, the mechanism, the dilution requirements to prevent skin irritation, the migraine evidence, and the comparison to other topical options.
Table of Contents
- The Göbel 1996 Trial — Acetaminophen Head-to-Head
- Göbel 1994 — Neurophysiology Mechanism Paper
- TRPM8 Cold-Receptor Counter-Irritant Mechanism
- Trigeminal Anatomy and Why the Temples Work
- Dilution Requirements and Skin Tolerance
- How Topical Peppermint Is Applied
- Migraine and the Borhani Haghighi 2010 Menthol Trial
- Nasal Inhalation for Migraine
- Comparison to Camphor-Menthol Balms, Methyl Salicylate, Capsaicin
- Cautions for Topical Use
- Key Research Papers
- Connections
- Featured Videos
The Göbel 1996 Trial — Acetaminophen Head-to-Head
The defining trial for peppermint oil in tension headache was conducted by Hartmut Göbel and colleagues at the Department of Neurology, Christian-Albrechts University in Kiel, Germany. Published in 1996 in Der Nervenarzt, the trial used a double-blind, four-arm, randomized placebo-controlled crossover design in 41 patients aged 18 to 65 with tension-type headache; 164 headache attacks were analysed. Each patient experienced all four treatment conditions across separate headache episodes:
- Treatment A: 10% peppermint oil in ethanol applied generously to the forehead and temples, plus an oral placebo capsule
- Treatment B: Placebo solution (90% ethanol with only traces of peppermint oil, added so the two solutions smelled alike) applied to the forehead and temples, plus 1,000 mg oral acetaminophen (paracetamol)
- Treatment C: 10% peppermint oil applied as in A, plus 1,000 mg oral acetaminophen
- Treatment D: Placebo solution applied, plus oral placebo capsule (double placebo)
The oil was spread widely across the forehead and temples and applied again after 15 and 30 minutes. Patients rated their headache in a diary after 15, 30, 45 and 60 minutes. The results, as reported by Göbel:
- Both active treatments produced statistically significant pain reduction compared to placebo
- The peppermint oil effect was detectable by 15 minutes and reached statistical significance vs placebo at the 15-minute mark
- The acetaminophen effect reached statistical significance at the 30-minute mark (consistent with oral absorption kinetics)
- By 60 minutes, both treatments produced approximately equivalent pain reduction
- There was no significant difference between the efficacy of 1,000 mg acetaminophen and the 10% peppermint oil solution
- Using peppermint and acetaminophen together gave an additive effect that remained below the significance threshold — suggesting that the two interventions affect the same final common pathway of tension-headache pain perception
- The patients reported no adverse events
The trial's finding is that topical 10% peppermint oil in ethanol applied to the forehead and temples produces tension-headache relief comparable to a standard adult dose of acetaminophen. This is genuinely remarkable for a non-pharmaceutical intervention — few topical herbal preparations produce effects in the same league as systemic oral analgesics.
In a 2016 review in Der Schmerz, Göbel's group reported that solutions of 10% peppermint oil in ethanol are licensed for treating tension-type headache in adults and in children over 6 years, that they appear in the treatment recommendations and guidelines of the professional societies, and that their efficacy is comparable to that of acetylsalicylic acid (aspirin) or paracetamol (acetaminophen).
Göbel 1994 — Neurophysiology Mechanism Paper
Two years before the head-to-head acetaminophen trial, the same Göbel group published a mechanism-focused study in Cephalalgia. This paper used neurophysiological measurements (cutaneous algesimetry, and the contingent negative variation (CNV) recorded on the electroencephalogram (EEG)) to characterize how peppermint oil and eucalyptus oil affect pain perception when applied to the temples and forehead. The volunteers were 32 healthy people given experimental pain, not headache patients. In a double-blind, placebo-controlled crossover design, four different preparations were sponged onto large areas of the forehead and temples.
Key findings from the 1994 mechanism paper:
- Peppermint oil with ethanol produced a significant pain-relieving effect, lowering sensitivity to experimental headache-type pain
- The mix of peppermint oil, eucalyptus oil and ethanol did something different: it improved performance on thinking tests and relaxed the muscles and the mind, but had little influence on pain sensitivity
- So the better thinking came from the three-part mix, while the pain effect came from peppermint oil with ethanol
- The effects were temporally consistent with the cooling sensation timeline — onset within minutes, peak at 15-20 minutes, decline by 60 minutes
The authors concluded that laboratory tests show these essential-oil preparations have significant effects on mechanisms linked to headache. Because the volunteers were healthy, the study measures effects on experimental pain, not on real headaches. This mechanism paper established that the pain reduction was not simply a placebo effect from the cooling sensation, but reflected a measurable change in central pain processing. The combination of peripheral cold-receptor activation, central pain modulation, and mild facial muscle relaxation appears to address tension-headache mechanism at multiple levels simultaneously.
TRPM8 Cold-Receptor Counter-Irritant Mechanism
The pharmacological basis for peppermint oil's topical headache effect is now well-mapped. L-menthol is the prototypical agonist of TRPM8 (transient receptor potential cation channel subfamily M member 8), the molecular sensor for cold temperatures. TRPM8 is expressed on:
- Cold-sensing primary afferent neurons in the skin
- Trigeminal sensory neurons innervating the face and scalp
- Sensory neurons in the nasal and oral mucosa
- Various non-neuronal tissues including prostate and bladder epithelium
When menthol binds TRPM8 on a cold-sensing neuron in the forehead or temple skin, the channel opens, calcium and sodium flow in, the neuron depolarizes, and the brain receives a signal interpreted as "cold." This is the source of the characteristic cooling sensation of peppermint, mint candy, and toothpaste.
The headache-relief mechanism comes from what happens centrally with this cold signal. In the spinal dorsal horn (and the analogous trigeminal nucleus caudalis for face and head pain), competing sensory inputs to second-order neurons follow the "gate control" principle — strong non-painful input (such as the cold sensation from menthol) inhibits transmission of painful input (the tension-headache nociceptive signal) at the same spinal/brainstem level. This is the same mechanism behind TENS units, rubbing a bumped knee, and ice packs on a sprained ankle. It is also why scratching reduces itch.
The counter-irritant principle requires that the non-painful or mildly-irritant input arrive at approximately the same spinal segment as the pain signal it is competing with. This is why topical peppermint on the forehead and temples affects forehead-and-temple tension headache — both signals enter the trigeminal nucleus caudalis at the same level. Peppermint applied to the abdomen would not similarly affect a tension headache, because the abdominal sensory input arrives at thoracic spinal segments rather than the trigeminal complex.
Trigeminal Anatomy and Why the Temples Work
The trigeminal nerve (cranial nerve V) has three major branches:
- V1 (ophthalmic): innervates the forehead, scalp anterior to the vertex, upper eyelid, nose, and frontal sinus
- V2 (maxillary): innervates the cheek, upper lip, upper teeth, nasal cavity floor, and maxillary sinus
- V3 (mandibular): innervates the lower jaw, lower lip, lower teeth, anterior tongue, and temporomandibular joint
Tension headache is mediated primarily through V1 (frontal pain) and through V3 contributions when temporomandibular muscle tension is involved. The standard topical peppermint application zones — forehead, temples, behind the ears — map directly to V1 distribution (forehead and temples) and the auriculotemporal branch of V3 (behind the ears). This is why the standard application pattern works: the menthol-induced cold signal enters the trigeminal nucleus caudalis at the same level as the headache pain signal, producing maximal counter-irritant gate-control inhibition.
Patients with primarily occipital tension headache — pain at the back of the skull, often from cervical muscle tension — may get less benefit from forehead-and-temple application because the occipital region is innervated by the greater occipital nerve (a branch of the C2 dorsal ramus) rather than the trigeminal system. For these patients, application to the occiput and posterior neck may work better, though this has not been formally trialed.
For more on tension headache pathophysiology and the full menu of treatment options, see our Headache page.
Dilution Requirements and Skin Tolerance
Pure undiluted peppermint essential oil applied directly to the skin can cause significant chemical irritation, blistering, and contact dermatitis. The standard topical headache preparation is 10% peppermint oil in a carrier — the dilution used in the Göbel 1996 trial and the standard for subsequent clinical work.
Carriers used include:
- Ethanol (70-95%): the Göbel trial preparation; evaporates quickly leaving the menthol on the skin; produces the strongest immediate cooling sensation
- Fractionated coconut oil: the most common choice for at-home preparations; oil-soluble peppermint disperses readily; gentle on skin
- Jojoba oil: very stable, long shelf life; good for sensitive skin
- Sweet almond oil: common cosmetic carrier; can cause reactions in those with nut allergies
- Aqueous (water-based) gels: menthol does not dissolve well in pure water; commercial menthol creams use a combined solvent system
Home preparations described by users combine 1 part peppermint essential oil with 9 parts carrier oil in a small glass roller bottle (10 mL total: 1 mL peppermint, 9 mL carrier). This gives a 10% preparation, the trial concentration (the trial itself used ethanol, not a carrier oil).
The maximum tolerated concentration before significant skin irritation is approximately 15-20% for most skin types. Going above 10% does not produce proportionally more headache benefit and substantially increases the risk of contact dermatitis. The Göbel 10% concentration represents the established sweet spot.
Patch testing — applying a small amount to the inner forearm and waiting 24 hours before facial application — is a common precaution described for first-time users, particularly those with known sensitive skin or other essential-oil reactions.
How Topical Peppermint Is Applied
In the Göbel 1996 trial the 10% peppermint oil solution was spread widely across the forehead and temples, and the application was repeated after 15 and 30 minutes. Home practice described by users and practitioners builds on that pattern:
- 2-4 drops (approximately 0.1-0.2 mL) of a 10% peppermint oil preparation on the fingertips
- Gentle circular massage into both temples for 30-60 seconds
- More preparation spread across the forehead, from the center outward
- Behind the ears when jaw (temporomandibular) tension is part of the headache
- The back of the neck and upper shoulders when neck tension is part of it
- The eyes, eyelids and inside of the nose are the areas where menthol causes intense burning; cool water, or whole milk (fat-soluble menthol disperses into milk fat), is the usual rinse after accidental eye contact
- Repeat applications after 30-60 minutes, and at 4-hour intervals, are described
- Oil left on the fingers is the usual way it reaches the eyes, which is why hand-washing after application is part of the routine
In the trial, pain was already significantly lower than with placebo at 15 minutes, and the reduction continued through the one-hour observation period. The full effect typically develops within 15-20 minutes of application, peaks at approximately 30 minutes, and declines over 60-90 minutes. There is no specific upper limit on daily applications; a persistent need for more than 4 applications per day is generally read as a sign that the headache is not controlled.
Migraine and the Borhani Haghighi 2010 Menthol Trial
Migraine is a different headache type from tension-type headache, and the peppermint evidence base for migraine is substantially smaller. The most-cited trial is Afshin Borhani Haghighi and colleagues at the Shiraz University of Medical Sciences in Iran, published in 2010 in the International Journal of Clinical Practice.
The Borhani Haghighi trial was a triple-blind crossover study in 35 people with migraine without aura (80% women, mean age 29.6), who treated 118 migraine attacks. Each patient used both solutions, applied to the skin of the forehead and temples: 10% menthol in ethanol, and as the placebo a weak 0.5% menthol in ethanol. Pain intensity, nausea, vomiting, and photophobia/phonophobia were assessed at 30 minutes, 1 hour, and 2 hours post-application. Key findings:
- The 10% menthol solution beat the placebo on being pain-free at 2 hours (p = 0.001) and on pain relief at 2 hours
- Approximately half the menthol-treated patients reported pain-free or mild-pain status at 2 hours, versus less than 20% with placebo
- It was also better on sustained pain-free and sustained pain-relief end-points
- Associated symptoms (nausea and/or vomiting, light and/or sound sensitivity) also improved more with menthol (p = 0.02)
- Adverse effects did not differ significantly between menthol and placebo (p = 0.13)
The trial size was modest (35 patients) and single-center, so the evidence is suggestive rather than definitive. However, the effect sizes were clinically meaningful, and the safety profile was excellent. Its authors concluded that menthol solution can be an efficacious, safe and tolerable option for stopping a migraine attack.
Pooled evidence is weaker than this single trial. A 2024 systematic review and meta-analysis in the Korean Journal of Family Medicine combined 7 randomized trials of essential oils for migraine (558 participants) and found no significant difference between essential oils and placebo; for the number of migraine attacks (4 trials, 242 participants) the difference was not significant (moderate-quality evidence).
For migraine prevention, the evidence is much weaker — preventive interventions like riboflavin, magnesium, coenzyme Q10 (CoQ10), and feverfew have stronger evidence bases.
For comprehensive migraine management, see our Migraine page.
Nasal Inhalation for Migraine
Beyond topical forehead application, some patients find that inhaling peppermint vapor through the nose during a migraine attack provides additional relief. The mechanism likely combines:
- TRPM8 activation on intranasal trigeminal afferents (V1 ethmoidal branch and V2 nasopalatine branch), producing the same cold-cooling counter-irritant effect as topical application
- Trigeminal arousal that produces mild central nervous system activation, which can counter the "hibernation" quality some migraine patients report during an attack
- Mild bronchodilation and increased subjective airflow, which can be useful when migraine-associated nasal congestion or sense of facial heaviness is prominent
- Possible serotonergic modulation, though the evidence here is speculative
One randomized trial has tested peppermint oil inside the nose. In 2019, Rafieian-Kopaei and colleagues in Iran gave 120 adults with migraine nose drops of 1.5% peppermint essential oil, 4% lidocaine (a local anaesthetic) or placebo. Headache intensity after treatment differed significantly between the groups (P < 0.001): 42.1% of the peppermint group and 41.5% of the lidocaine group responded strongly, and fewer did with placebo. These were drops, not inhaled vapour.
Methods people describe include holding an open bottle of peppermint essential oil under the nose for 1-2 minutes (avoiding direct nostril contact), placing 2-3 drops on a tissue or cotton ball and inhaling, using an aromatherapy nasal inhaler (a small plastic tube containing a peppermint-saturated cotton wick), or steam inhalation by adding 3-5 drops of peppermint oil to a bowl of hot water and draping a towel over the head.
Nasal inhalation is usually described as an addition to topical application or to pharmaceutical migraine treatments (triptans, nonsteroidal anti-inflammatory drugs (NSAIDs)) rather than as a stand-alone therapy. Forehead application plus nasal inhalation is described as the approach that gives the most trigeminal counter-irritant stimulation; no trial has tested the combination.
Comparison to Camphor-Menthol Balms, Methyl Salicylate, Capsaicin
Peppermint is not the only topical agent used for headache and musculoskeletal pain. The most common alternatives:
- Camphor-menthol balms — a traditional Asian balm formulation combines menthol (the same active component as peppermint), camphor (TRPM8 and TRPV1 activator with additional anesthetic effects), cajuput oil, and clove oil. The combination of menthol and camphor produces both cooling (TRPM8) and warming (TRPV1) sensations simultaneously, which can be more effective as a counter-irritant for some patients. Such balms come in warmer (more clove or capsaicin) and cooler (more menthol) versions.
- Methyl salicylate (oil of wintergreen) — the active component of many sports rubs and menthol creams. Methyl salicylate is absorbed transdermally and provides a local nonsteroidal anti-inflammatory drug (NSAID) effect (inhibition of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) at the application site) in addition to a counter-irritant cooling/burning sensation from accompanying menthol or capsaicin. Stronger anti-inflammatory effect than pure peppermint but with higher systemic absorption and salicylate-toxicity risk if applied to large surface areas.
- Capsaicin — the active component of chili peppers; available as 0.025% over-the-counter (OTC) capsaicin cream and 0.075% prescription preparations. Capsaicin activates TRPV1 (the heat-and-pain receptor) producing initial intense burning followed by gradual depletion of substance P in primary afferent neurons. Not used for tension headache (the initial burning intensifies pain), but used for trigeminal neuralgia, post-herpetic neuralgia, and cluster headache (intranasal capsaicin).
- Lavender essential oil — modest evidence for migraine prevention via inhalation, primarily through serotonergic and GABAergic central effects rather than counter-irritation. Different mechanism from peppermint.
- Eucalyptus oil — in the Göbel 1994 study of healthy volunteers, peppermint oil with ethanol lowered pain sensitivity, while the peppermint-eucalyptus-ethanol mix improved thinking and relaxation but had little influence on pain. Eucalyptus combined with peppermint is common in commercial preparations (vapour rubs, certain massage balms) and may provide synergistic respiratory effects.
For tension headache specifically, peppermint and camphor-menthol balms (largely menthol plus camphor) are the topical options most used and have the best evidence base. Methyl salicylate and capsaicin are more useful for musculoskeletal pain than headache.
Cautions for Topical Use
- Eye contact — the most common adverse event; produces intense burning and tearing. Oil left on the hands is the usual route. Cool water, or whole milk (menthol disperses into milk fat), is the usual rinse; rubbing spreads the oil further.
- Mucous membrane contact — on the nostrils, lips (especially chapped lips) and other mucosal surfaces the burning sensation is intense and persistent.
- Infants and very young children — menthol products on the face, chest or under the nose are the concern in infants and children under 2 years old. Menthol vapor has been associated with rare cases of laryngospasm and apnea in this age group. The American Academy of Pediatrics advises against menthol-containing products in children under 2; some authorities extend this to under 5.
- Pregnancy — moderate use of topical peppermint preparations is generally considered safe in pregnancy. The cautions concern high-concentration applications (greater than 10%) and direct contact inside the nostrils.
- Contact dermatitis — some individuals develop allergic contact dermatitis to topical peppermint after repeated exposure. Manifests as itching, redness, and small papules in the application area.
- Drug interactions (topical) — minimal systemic absorption from properly diluted topical use; clinically significant drug interactions are not expected at standard headache-application doses
- Asthma trigger — intense peppermint vapor inhalation has rarely been reported to trigger bronchospasm in patients with sensitive asthma.
Key Research Papers
- Göbel H, Schmidt G, Soyka D (1994). Effect of peppermint and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parameters. Cephalalgia 14(3):228-34. — PubMed PMID: 7954745
- Göbel H, Fresenius J, Heinze A, Dworschak M, Soyka D (1996). [Effectiveness of Oleum menthae piperitae and paracetamol in therapy of headache of the tension type]. Der Nervenarzt 67(8):672-81. — PubMed PMID: 8805113
- Göbel H, Heinze A, Heinze-Kuhn K, Göbel A, Göbel C (2016). [Peppermint oil in the acute treatment of tension-type headache]. Der Schmerz 30(3):295-310. — PubMed PMID: 27106030
- Borhani Haghighi A, Motazedian S, Rezaii R, Mohammadi F, Salarian L, Pourmokhtari M, Khodaei S, Vossoughi M, Miri R (2010). Cutaneous application of menthol 10% solution as an abortive treatment of migraine without aura: a randomised, double-blind, placebo-controlled, crossed-over study. International Journal of Clinical Practice 64(4):451-6. — PubMed PMID: 20456191
- Rafieian-Kopaei M, Hasanpour-Dehkordi A, Lorigooini Z, Deris F, Solati K, Mahdiyeh F (2019). Comparing the effect of intranasal lidocaine 4% with peppermint essential oil drop 1.5% on migraine attacks: a double-blind clinical trial. International Journal of Preventive Medicine 10:121. — PubMed PMID: 31404204
- Murtey P, Noor NM, Ishak A, Idris NS (2024). Essential oils as an alternative treatment for migraine headache: a systematic review and meta-analysis. Korean Journal of Family Medicine 45(1):18-26. — PubMed PMID: 37899272
- McKemy DD, Neuhausser WM, Julius D (2002). Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416(6876):52-8. — PubMed PMID: 11882888
- Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA, Story GM, Earley TJ, Dragoni I, McIntyre P, Bevan S, Patapoutian A (2002). A TRP channel that senses cold stimuli and menthol. Cell 108(5):705-15. — PubMed PMID: 11893340
- Liu B, Fan L, Balakrishna S, Sui A, Morris JB, Jordt SE (2013). TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain. Pain 154(10):2169-2177. — PubMed PMID: 23820004
- Diamond S, Freitag FG (2001). The use of ibuprofen plus caffeine to treat tension-type headache. Current Pain and Headache Reports 5(5):472-8 (context on another non-prescription option; the paper does not study peppermint). — PubMed PMID: 11560814
- Hawthorn M, Ferrante J, Luchowski E, Rutledge A, Wei XY, Triggle DJ (1988). The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations. Alimentary Pharmacology & Therapeutics 2(2):101-18 (mechanism cross-reference). — PubMed PMID: 2856502
- Headache Classification Committee of the International Headache Society (IHS) (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1-211. — PubMed PMID: 29368949